Concepedia

Author

Catalina Alamón

Universidad de la República de Uruguay

Also Known As

Catalina Alamón

14

Publications

283

Citations

8

H-Index

12

Concepts

All Affiliations

Universidad de la República de UruguayInstitut de Ciència de Materials de BarcelonaInstitut Pasteur de MontevideoComisión Nacional de Energía AtómicaTechnion – Israel Institute of Technology
CA

About

Catalina Alamón is an author at Universidad de la República de Uruguay specializing in tumor biology, cancer therapeutics, and glioma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

49

2

Pathology

1

1

49

3

Pharmacology

1

1

49

4

Cancer Therapeutics

1

1

49

5

Molecular Oncology

1

1

49

Catalina Alamón

×

8

Publications

274

Citations

8

H-Index

YearCitations

Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D‐Aromatic‐Boron‐Rich‐Cluster into the 4‐Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment

Marcos Couto, María Fernanda García, Catalina Alamón,

Chemistry - A European Journal

2017

78

Bimodal Therapeutic Agents Against Glioblastoma, One of the Most Lethal Forms of Cancer

Marcos Couto, Catalina Alamón, S. Nievas,

Chemistry - A European Journal

2020

49

Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

Marcos Couto, Catalina Alamón, María Jesús García García,

Cells

2020

35

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

Catalina Alamón, Belén Dávila, María Fernanda García,

Cancers

2020

29

PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease

Maite Duhalde Vega, Daniela Olivera, Gustavo Gastão Davanzo,

Science Advances

2022

24

Carboranylanilinoquinazoline EGFR-Inhibitors: Toward ‘Lead-to-Candidate’ Stage in the Drug-Development Pipeline

Marcos Couto, Catalina Alamón, Carina Sánchez,

Future Medicinal Chemistry

2019

22

A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: <i>In Vitro</i> and <i>in Vivo</i> Exploration

Catalina Alamón, Belén Dávila, María Fernanda García,

Molecular Pharmaceutics

2023

22

The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS

Mariángeles Kovacs, Catalina Alamón, Cecilia Maciel,

Acta Neuropathologica Communications

2021

15

Page 1